Home Considering a new standard of care in schizophrenia As a psychiatrist, I have observed that schizophrenia is a widely known, but poorly understood mental health condition.
News NHSBSA releases latest Medicines Used in Mental Health data Covering October to December 2022, the report recorded 21.7m antidepressant items prescribed.
News Novo puts $285m into monthly GLP-1 based on Ascendis tech Novo Nordisk has partnered with Ascendis Pharma on less frequently dosed drugs for obesity and other metabolic diseases, starting with a once-monthly GLP-1 receptor agonist.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
